SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-04-095071
Filing Date
2004-05-27
Accepted
2004-05-27 06:16:09
Documents
9

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA INC--2ND AMENDMENT ds3a.htm S-3/A 1076417
2 CONSENT OF KPMG LLP dex232.htm EX-23.2 1685
3 FORM OF LETTER OF TRANSMITTAL dex991.htm EX-99.1 93257
4 FORM OF NOTICE OF GUARANTEED DELIVERY dex992.htm EX-99.2 21076
5 FORM OF LETTER TO BROKERS dex993.htm EX-99.3 13033
6 FORM OF LETTER TO CLIENTS dex994.htm EX-99.4 19774
7 FORM W-9 dex995.htm EX-99.5 30078
8 GRAPHIC g34596g21k51.jpg GRAPHIC 280676
9 GRAPHIC g34596g43r10.jpg GRAPHIC 14728
  Complete submission text file 0001193125-04-095071.txt   1553141
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-113791 | Film No.: 04833590
SIC: 2834 Pharmaceutical Preparations